NextCure NXTC
NASDAQ NXTC
$6.40 +0.17 (+2.73%)
At close: Nov 13, 2026 · 4:00 PM EST

NextCure (NXTC) Gains (Losses) on Sale of Assets & Investments (2019 - 2026)

Updated

NextCure (NXTC) recorded Gains (Losses) on Sale of Assets & Investments of $3,000 in Q3 2026, down 87.5% from $24,000 a year earlier.

Analysis

NextCure (NXTC) Gains (Losses) on Sale of Assets & Investments (2019 - 2026) Analysis & Trends

On a TTM basis, NextCure's Gains (Losses) on Sale of Assets & Investments came in at -$17,000 as of Sep 30, 2026; for FY2025, it was $17,000, down 92.5% from FY2024.

  • Annual Gains (Losses) on Sale of Assets & Investments has a five-year compound annual growth rate of -53.5% (FY2020 to FY2025).
  • Across earlier years, Gains (Losses) on Sale of Assets & Investments came in at $226,000 in FY2024 (-82.2%), $1.27 million in FY2023, -$831,000 in FY2022 and -$1.44 million in FY2021.
  • Quarterly Gains (Losses) on Sale of Assets & Investments has ranged from -$1.54 million in Q1 2022 to $691,000 in Q1 2023 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$1,000 (Q2 2026), -$23,000 (Q1 2026) and $4,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 NextCure 29.30 Mn -71.08 Mn - 3,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3,000.00
Jun 30, 2026 -1,000.00
Mar 31, 2026 -23,000.00
Dec 31, 2025 4,000.00
Sep 30, 2025 24,000.00
Jun 30, 2025 -7,000.00
Mar 31, 2025 -4,000.00
Dec 31, 2024 -72,000.00
Sep 30, 2024 162,000.00
Jun 30, 2024 96,000.00
Mar 31, 2024 40,000.00
Dec 31, 2023 381,000.00
Sep 30, 2023 322,000.00
Jun 30, 2023 -122,000.00
Mar 31, 2023 691,000.00
Dec 31, 2022 -831,000.00
Sep 30, 2022 -56,000.00
Jun 30, 2022 -141,000.00
Mar 31, 2022 -1.54 Mn
Dec 31, 2021 -534,000.00
API Access

NextCure Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=NXTC&period=max&api_key=YOUR_API_KEY